LyprinolIs it a useful anti-inflammatory agent?

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Doggrell, Sheila A ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CARRAGEENAN; CHOLESTEROL ESTER; COLLAGEN TYPE 2; CYTOKINE; DIFLUNISAL; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; HISTAMINE; IBUPROFEN; ICOSAPENTAENOIC ACID; LEUKOTRIENE; LIPID; LIPOXYGENASE; LYPRINOL; MEFENAMIC ACID; NAPROXEN; OMEGA 3 FATTY ACID; PENTOXIFYLLINE; PLACEBO; POLAR LIPID; POLYUNSATURATED FATTY ACID; PREDNISONE; PROSTAGLANDIN; STEROL DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZYMOSAN;

ABSENCE OF SIDE EFFECTS; ALLERGIC ASTHMA; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ATOPY; CARDIOVASCULAR RISK; CHEMICAL COMPOSITION; DOG; ENTERITIS; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; INTESTINAL MUCOSITIS; ISCHEMIC HEART DISEASE; MORNING STIFFNESS; MUCOSA INFLAMMATION; MUSSEL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OSTEOARTHRITIS; PERNA CANALICULUS; PLACEBO EFFECT; POLYARTHRITIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RECTUM HEMORRHAGE; REVIEW; RHEUMATOID ARTHRITIS; RISK REDUCTION; SPLEEN CELL; STROKE; SWELLING; UTERUS CONTRACTION; VISUAL ANALOG SCALE; WEIGHT REDUCTION;

EID: 80053513243     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nep030     Document Type: Review

References (40)

1. Lyprinol,. Available at http://www.lyprinol.com
2. Social Issues Research Centre,. September 2008, http://www.sirc.org/ media/mediasept2399.html
3. Claims of media manipulation after NZ diet food frenzy,. September 2008, http://www.abc.net.au/am/stories/s41055.htm
4. Introductory information about Lyprinol,. September 2008, http://www.baranboost.com/lyprinolpresenterenglish.pdf
5. Lyprinol,. September 2008, http://www.lyprinol-arthritis.com/
6. Food and Drug Administration,. September 2008, www.fda.gov/cder/warn/ cyber/2007/UL4.pdf
7. Lyprinol,. September 2008, www.lyprinolusa.com/
8. Macrides T. A., Kalafatis N., Super-critical lipid extract from mussels having anti-inflammatory activity. US Patent no. 6083536, 2000
9. Mobicosa capsulesa natural arthritis treatment,. September 2008, http://www.naturalmobility.com.au/mobicosacapsules.html
10. Murphy K. J., Mooney B. D., Mann N. J., Nichols P. D., Sinclair A. J., Lipid, FA, and sterol composition of New Zealand green lipped mussel (Perna canaliculus) and Tasmanian blue mussel (Mytilus edulis) Lipids 2002 37 6 587 595 (Pubitemid 34734094)
11. Treschow A. P., Hodges L. D., Wright P. F. A., Wynne P. M., Kalafatis N., Macrides T. A., Novel anti-inflammatory -3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus Comparative Biochemistry and Physiology B 2007 147 4 645 656 (Pubitemid 46920995)
12. Whitehouse M. W., Macrides T. A., Kalafatis N., Betts W. H., Haynes D. R., Broadbent J., Anti-inflammatory activity of a lipid fraction (Lyprinol) from the NZ green-lipped mussel Inflammopharmacology 1997 5 3 237 246 (Pubitemid 27459731)
13. McPhee S., Hodges L. D., Wright P. F. A., Wynne P. M., Kalafatis N., Harney D. W., Macrides T. A., Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus Comparative Biochemistry and Physiology B 2007 146 3 346 356
14. Mani S., Lawson J. W., In vitro modulation of inflammatory cytokine and IgG levels by extracts of Perna canaliculus BMC Complementary and Alternative Medicine 2006 6, article no. 1
15. Kosuge T., Tsuji K., Ishida H., Yamaguchi T., Isolation of an anti-histaminic substance from green-lipped mussel (Perna canaliculus) Chemical and Pharmaceutical Bulletin 1986 34 11 4825 4828 (Pubitemid 17226363)
16. Lee C.-H., Lum J. H.-K., Ng C. K.-C., McKay J., Butt Y. K.-C., Wong M.-S., Lo S. C.-L., Pain controlling and Cytokine-regulating effects of lyprinol, a lipid extract of perna canaliculus, in a rat Adjuvant-induced arthritis model Evidence-Based Complementary and Alternative Medicine 2009 6 2 239 245
17. Lawson B. R., Belkowski S. M., Whitesides J. F., Davis P., Lawson J. W., Immunomodulation of murine collagen-induced arthritis by N, N-dimethylglycine and a preparation of Perna canaliculus BMC Complementary and Alternative Medicine 2007 7, article no. 20
18. Lee C.-H., Butt Y. K.-C., Wong M.-S., Lo S. C.-L., Differential protein expression induced by a lipid extract of Perna canaliculus in splenocytes of rats with adjuvant-induced arthritis Inflammopharmacology 2008 16 4 188 194
19. Whitehouse M. W., Butters D. E., Combination anti-inflammatory therapy: synergism in rats of NSAIDs/corticosteroids with some herbal/animal products Inflammopharmacology 2003 11 46 453 464 (Pubitemid 38175954)
20. Whitehouse M. W., Anti-TNF- therapy for chronic inflammation: reconsidering pentoxifylline as an alternative to therapeutic protein drugs Inflammopharmacology 2004 12 3 223 227 (Pubitemid 39536679)
21. Singh M., Hodges L. D., Wright P. F. A., Cheah D. M. Y., Wynne P. M., Kalafatis N., Macrides T. A., The CO 2 -SFE crude lipid extract and the free fatty acid extract from Perna canaliculus have anti-inflammatory effects on adjuvant-induced arthritis in rats Comparative Biochemistry and Physiology B 2008 149 2 251 258 (Pubitemid 350300008)
22. Tenikoff D., Murphy K. J., Le M., Howe P. R., Howarth G. S., Lyprinol (stabilised lipid extract of New Zealand green-lipped mussel): a potential preventative treatment modality for inflammatory bowel disease Journal of gastroenterology 2005 40 4 361 365
23. Torres D. M., Tooley K. L., Butler R. N., Smith C. L., Geier M. S., Howarth G. S., Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis Cancer Biology and Therapy 2008 7 2 295 302 (Pubitemid 351590440)
24. Shiels I.-A., Whitehouse M.-W., Lyprinol: anti-inflammatory and uterine-relaxant activities in rats, with special reference to a model for dysmenorrhoea Allergie et Immunologie 2000 32 7 279 283
25. Bui L. M., Bierer T. L., Influence of green-lipped mussel (Perna canaliculus) in alleviating signs of arthritis is dogs Veterinary Therapeutics 2001 2 2 101 111 (Pubitemid 33814421)
26. Dobenecker B., Beetz Y., Kienzle E0, A placebo-controlled double-blind study on the effect of nutraceuticals (chondroitin sulphate and mussel extract) in dogs with joint diseases as perceived by their owners Journal of Nutrition 2002 132 1690S 1691S (Pubitemid 34602735)
27. Pollard B., Guilford W. G., Ankenbauer-Perkins K. L., Hedderley D., Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease New Zealand Veterinary Journal 2006 54 3 114 118
28. Hielm-Bjrkman A., Tulamo R.-M., Salonen H., Raekallio M., Evaluating complementary therapies for canine osteoarthritis part I: green-lipped mussel (Perna canaliculus) Evidence-Based Complementary and Alternative Medicine 2009 6 3 365 373
29. Gibson S. L. M., Gibson R. G., The treatment of arthritis with a lipid extract of Perna canaliculus: a randomized trial Complementary Therapies in Medicine 1998 6 3 122 126 (Pubitemid 28457024)
30. Babul N., Noveck R., Chipman H., Roth S. H., Gana T., Albert K., Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee Journal of Pain and Symptom Management 2004 28 1 59 71 (Pubitemid 38829673)
31. Pavelka K., Tr T., Karpa K., Vtek P., Sedlkov M., Vlaskov V., Bhmov J., Rovensk J., The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee Arthritis and Rheumatism 2007 56 4055 4064
32. Yang K. G. A., Raijmakers N. J. H., van Arkel E. R. A., Caron J. J., Rijk P. C., Willems W. J., Zijl J. A. C., Verbout A. J., Dhert W. J. A., Saris D. B. F., Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial Osteoarthritis and Cartilage 2008 16 4 498 505 (Pubitemid 351444567)
33. Cho S. H., Jung Y. B., Seong S. C., Park H. B., Byun K. Y., Lee D. C., Song E. K., Son J. H., Clinical efficacy and safety of Lyprinol, a patented extract from New Zealand green-lipped mussel (Perna Canaliculus) in patients with osteoarthritis of the hip and knee: a multicenter 2-month clinical trial European Annals of Allergy and Clinical Immunology 2003 35 6 212 216 (Pubitemid 36781878)
34. Lau C. S., Chiu P. K. Y., Chu E. M. Y., Cheny I. Y. M., Tang W. M., Man R. Y. K., Halpern GM: treatment of knee osteoporosis with Lyprinol, lipid extract of the green-lipped mussel a double-blind placebo-controlled study Progress in Nutrition 2004 6 17 31 (Pubitemid 39117280)
35. Gruenwald J., Graubaum H. J., Hansen K., Grube B., Efficacy and tolerability of a combination of Lyprinol and high concentrations of EPA and DHA in inflammatory rheumatoid disorders Advances in Therapy 2004 21 197 201 (Pubitemid 39350478)
36. Emelyanov A., Fedoseev G., Krasnoschekova O., Abulimity A., Trendeleva T., Barnes P. J., Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial European Respiratory Journal 2002 20 596 600
37. Calder P. C., n-3 polyunsaturated fatty acids, inflammation and inflammatory disease American Journal of Clinical Nutrition 2006 83 6 supplement 1505S 1519S (Pubitemid 44713092)
38. Goldberg R. J., Katz J., A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain Pain 2006 129 210 223
39. Feagan B. G., Sandborn W. J., Mittmann U., Bar-Meir S., DHaens G., Bradette M., Omega-3 free fatty acids for the maintenance of remission in Crohn disease; the EPIC randomized controlled trial Journal of the American Medical Association 2008 299 1690 1697 (Pubitemid 351519866)
40. De Ley M., de Vos R., Hommes D. W., Stokkers P., Fish oil for induction of remission in ulcerative colitis Cochrane Database of Systematic Reviews 2007 4, article CD005986